Literature DB >> 21458276

Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase.

Surya K De1, Elisa Barile, Vida Chen, John L Stebbins, Jason F Cellitti, Thomas Machleidt, Coby B Carlson, Li Yang, Russell Dahl, Maurizio Pellecchia.   

Abstract

We report comprehensive structure-activity relationship studies on a novel series of c-Jun N-terminal kinase (JNK) inhibitors. Intriguingly, the compounds have a dual inhibitory activity by functioning as both ATP and JIP mimetics, possibly by binding to both the ATP binding site and to the docking site of the kinase. Several of such novel compounds display potent JNK inhibitory profiles both in vitro and in cell.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458276      PMCID: PMC3089059          DOI: 10.1016/j.bmc.2011.03.017

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  32 in total

Review 1.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

Authors:  G Pearson; F Robinson; T Beers Gibson; B E Xu; M Karandikar; K Berman; M H Cobb
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

Review 2.  Biotransformation reactions of five-membered aromatic heterocyclic rings.

Authors:  Deepak K Dalvie; Amit S Kalgutkar; S Cyrus Khojasteh-Bakht; R Scott Obach; John P O'Donnell
Journal:  Chem Res Toxicol       Date:  2002-03       Impact factor: 3.739

Review 3.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 4.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

Authors:  J M Kyriakis; J Avruch
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

5.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.

Authors:  B L Bennett; D T Sasaki; B W Murray; E C O'Leary; S T Sakata; W Xu; J C Leisten; A Motiwala; S Pierce; Y Satoh; S S Bhagwat; A M Manning; D W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  Identification of the critical features of a small peptide inhibitor of JNK activity.

Authors:  Renae K Barr; Tulene S Kendrick; Marie A Bogoyevitch
Journal:  J Biol Chem       Date:  2002-01-14       Impact factor: 5.157

7.  Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.

Authors:  C Bonny; A Oberson; S Negri; C Sauser; D F Schorderet
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

8.  Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide.

Authors:  Hideaki Kaneto; Yoshihisa Nakatani; Takeshi Miyatsuka; Dan Kawamori; Taka-aki Matsuoka; Munehide Matsuhisa; Yoshitaka Kajimoto; Hidenori Ichijo; Yoshimitsu Yamasaki; Masatsugu Hori
Journal:  Nat Med       Date:  2004-09-26       Impact factor: 53.440

9.  Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125.

Authors:  Yong-Seok Heo; Su-Kyoung Kim; Chang Il Seo; Young Kwan Kim; Byung-Je Sung; Hye Shin Lee; Jae Il Lee; Sam-Yong Park; Jin Hwan Kim; Kwang Yeon Hwang; Young-Lan Hyun; Young Ho Jeon; Seonggu Ro; Joong Myung Cho; Tae Gyu Lee; Chul-Hak Yang
Journal:  EMBO J       Date:  2004-05-13       Impact factor: 11.598

Review 10.  Targeting JNK for therapeutic benefit: from junk to gold?

Authors:  Anthony M Manning; Roger J Davis
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

View more
  2 in total

Review 1.  Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases.

Authors:  Michael J Schnieders; Tamer S Kaoud; Chunli Yan; Kevin N Dalby; Pengyu Ren
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  A fluorescence-based assay for p38α recruitment site binders: identification of rooperol as a novel p38α kinase inhibitor.

Authors:  Jing Li; Tamer S Kaoud; Jake LeVieux; Brad Gilbreath; Swapna Moharana; Kevin N Dalby; Sean M Kerwin
Journal:  Chembiochem       Date:  2012-12-06       Impact factor: 3.164

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.